Stocktoria
PLUS THERAPEUTICS, INC. PSTV
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2000-08-09
PLUS THERAPEUTICS, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.2M | $5.8M | $4.9M | — | — | — | — | $3.7M | $2.7M | $4.7M |
| Gross profit | — | — | — | — | — | — | — | — | $146,000 | $1.9M |
| R&D expense | $8.4M | $10.6M | $9.7M | $9.7M | — | $2.7M | $5.4M | $5.5M | $11.7M | $16.2M |
| Operating income | -$15.3M | -$14.7M | -$13.3M | -$19.7M | -$12.5M | -$9.6M | -$3.7M | -$8.8M | -$20.7M | -$19.7M |
| Interest expense | — | — | $395,000 | $711,000 | $932,000 | $1.1M | $1.9M | $1.9M | $2.0M | $2.6M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$22.4M | -$13.0M | -$13.3M | -$20.3M | -$13.4M | -$8.2M | -$10.9M | -$12.6M | -$22.7M | -$22.0M |
| EPS (diluted) | $-0.29 | $-2.34 | $-4.24 | $-11.58 | $-1.11 | — | — | — | — | — |
| Operating cash flow | -$20.8M | -$10.6M | -$12.9M | -$13.0M | -$10.3M | -$8.4M | -$5.9M | -$12.0M | -$18.1M | -$19.5M |
| Free cash flow | -$20.8M | -$10.7M | -$13.0M | — | — | — | -$6.0M | -$12.1M | -$18.4M | -$19.6M |
| Cash & equivalents | $4.3M | $76,000 | $8.6M | $18.1M | $18.4M | $8.3M | $17.6M | $5.3M | $9.6M | $12.6M |
| Inventory | — | — | — | — | — | — | $107,000 | $107,000 | $3.2M | $3.7M |
| Total assets | $16.3M | $6.6M | $11.4M | $23.9M | $22.0M | $12.1M | $23.2M | $24.0M | $31.6M | $34.6M |
| Total liabilities | $12.3M | $15.6M | $12.7M | $17.4M | $11.1M | $9.1M | $22.1M | $18.8M | $18.6M | $23.6M |
| Shareholders' equity | $4.0M | -$8.9M | -$1.3M | $6.4M | $10.8M | $3.0M | $1.2M | $5.2M | $13.0M | $11.0M |
Growth · year-over-year · Revenue CAGR 2.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -10.5% | +18.5% | — | — | — | — | — | +36.5% | -42.2% | -3.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.